KDM2B/FBXL10 targets c-Fos for ubiquitylation and degradation in response to mitogenic stimulation

Oncogene

Volumn 35, Issue 32, 2016, Pages 4179-4190

  Han, X R ^a,b   Zha, Z ^a,b   Yuan, H X ^a   Feng, X ^a,b   Xia, Y K ^a,b   Lei, Q Y ^a   Guan, K L ^a,c   Xiong, Y ^a,b,d  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c San Diego   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; F BOX PROTEIN; FBXL10 PROTEIN; KDM2B PROTEIN; PROTEIN; PROTEIN C FOS; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; HISTONE DEMETHYLASE; KDM2A PROTEIN, HUMAN; MITOGENIC AGENT;

ARTICLE; CELL PROLIFERATION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; MITOGENICITY; MULTIPLE CANCER; MUTATION; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; UBIQUITINATION; DRUG EFFECTS; GENETICS; HEK293 CELL LINE; HELA CELL LINE; METABOLISM; PHOSPHORYLATION;

CELL PROLIFERATION; EPIDERMAL GROWTH FACTOR; F-BOX PROTEINS; HEK293 CELLS; HELA CELLS; HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; MITOGENS; MUTATION; PHOSPHORYLATION; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-FOS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84953290297     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2015.482     Document Type: Article

References (35)

1. Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 2003; 3: 859-868.
2. Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol 2002; 4: E131-E136.
3. Greenberg ME, Ziff EB. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 1984; 311: 433-438.
4. Rauscher FJ III, Sambucetti LC, Curran T, Distel RJ, Spiegelman BM. Common DNA binding site for Fos protein complexes and transcription factor AP-1. Cell 1988; 52: 471-480.
5. Chiu R, Boyle WJ, Meek J, Smeal T, Hunter T, Karin M. The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell 1988; 54: 541-552.
6. Sassone-Corsi P, Ransone LJ, Lamph WW, Verma IM. Direct interaction between fos and jun nuclear oncoproteins: role of the 'leucine zipper' domain. Nature 1988; 336: 692-695.
7. Glover JN, Harrison SC. Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA. Nature 1995; 373: 257-261.
8. Nakakuki T, Birtwistle MR, Saeki Y, Yumoto N, Ide K, Nagashima T et al. Ligandspecific c-Fos expression emerges from the spatiotemporal control of ErbB network dynamics. Cell 2010; 141: 884-896.
9. Treisman R. Journey to the surface of the cell: Fos regulation and the SRE. EMBO J 1995; 14: 4905-4913.
10. Gille H, Sharrocks AD, Shaw PE. Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature 1992; 358: 414-417.
11. Okazaki K, Sagata N. The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells. EMBO J 1995; 14: 5048-5059.
12. Stancovski I, Gonen H, Orian A, Schwartz AL, Ciechanover A. Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes. Mol Cell Biol 1995; 15: 7106-7116.
13. Chen RH, Abate C, Blenis J. Phosphorylation of the c-Fos transrepression domain by mitogen-activated protein kinase and 90-kDa ribosomal S6 kinase. Proc Natl Acad Sci USA 1993; 90: 10952-10956.
14. Bakiri L, Reschke MO, Gefroh HA, Idarraga MH, Polzer K, Zenz R et al. Functions of Fos phosphorylation in bone homeostasis, cytokine response and tumourigenesis. Oncogene 2011; 30: 1506-1517.
15. Sasaki T, Kojima H, Kishimoto R, Ikeda A, Kunimoto H, Nakajima K. Spatiotemporal regulation of c-Fos by ERK5 and the E3 ubiquitin ligase UBR1, and its biological role. Mol Cell 2006; 24: 63-75.
16. Gilley R, March HN, Cook SJ. ERK1/2, but not ERK5, is necessary and sufficient for phosphorylation and activation of c-Fos. Cell Signal 2009; 21: 969-977.
17. He J, Shen L, Wan M, Taranova O, Wu H, Zhang Y. Kdm2b maintains murine embryonic stem cell status by recruiting PRC1 complex to CpG islands of developmental genes. Nat Cell Biol 2013; 15: 373-384.
18. Liang G, He J, Zhang Y. Kdm2b promotes induced pluripotent stem cell generation by facilitating gene activation early in reprogramming. Nat Cell Biol 2012; 14: 457-466.
19. He J, Kallin EM, Tsukada Y, Zhang Y. The H3K36 demethylase Jhdm1b/Kdm2b regulates cell proliferation and senescence through p15(Ink4b). Nat Struct Mol Biol 2008; 15: 1169-1175.
20. Pfau R, Tzatsos A, Kampranis SC, Serebrennikova OB, Bear SE, Tsichlis PN. Members of a family of JmjC domain-containing oncoproteins immortalize embryonic fibroblasts via a JmjC domain-dependent process. Proc Natl Acad Sci USA 2008; 105: 1907-1912.
21. Kottakis F, Foltopoulou P, Sanidas I, Keller P, Wronski A, Dake BT et al. NDY1/KDM2B functions as a master regulator of polycomb complexes and controls selfrenewal of breast cancer stem cells. Cancer Res 2014; 74: 3935-3946.
22. He J, Nguyen AT, Zhang Y. KDM2b/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia. Blood 2011; 117: 3869-3880.
23. Tzatsos A, Paskaleva P, Ferrari F, Deshpande V, Stoykova S, Contino G et al. KDM2B promotes pancreatic cancer via Polycomb-dependent and-independent transcriptional programs. J Clin Invest 2013; 123: 727-739.
24. Tsukada Y, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH, Tempst P et al. Histone demethylation by a family of JmjC domain-containing proteins. Nature 2006; 439: 811-816.
25. Farcas AM, Blackledge NP, Sudbery I, Long HK, McGouran JF, Rose NR et al. KDM2B links the polycomb repressive complex 1 (PRC1) to recognition of CpG islands. eLife 2012; 1: e00205.
26. Wu X, Johansen Jens V, Helin K. Fbxl10/Kdm2b recruits polycomb repressive complex 1 to CpG islands and regulates H2A ubiquitylation. Mol Cell 2013; 49: 1134-1146.
27. Gearhart MD, Corcoran CM, Wamstad JA, Bardwell VJ. Polycomb group and SCF ubiquitin ligases are found in a novel BCOR complex that is recruited to BCL6 targets. Mol Cell Biol 2006; 26: 6880-6889.
28. Koyama-Nasu R, David G, Tanese N. The F-box protein Fbl10 is a novel transcriptional repressor of c-Jun. Nat Cell Biol 2007; 9: 1074-1080.
29. Bai C, Sen P, Hofmann K, Ma L, Goebl M, Harper JW et al. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 1996; 86: 263-274.
30. Skowyra D, Craig KL, Tyers M, Elledge SJ, Harper JW. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell 1997; 91: 209-219.
31. Feldman RM, Correll CC, Kaplan KB, Deshaies RJ. A complex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p. Cell 1997; 91: 221-230.
32. Zheng N, Schulman BA, Song L, Miller JJ, Jeffrey PD, Wang P et al. Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 2002; 416: 703-709.
33. Bartke T, Vermeulen M, Xhemalce B, Robson SC, Mann M, Kouzarides T. Nucleosome-interacting proteins regulated by DNA and histone methylation. Cell 2010; 143: 470-484.
34. Maher VM, Heflich RH, McCormick JJ. Repair of DNA damage induced in human fibroblasts by N-substituted aryl compounds. Natl Cancer Inst Monogr 1981; 58: 217-222.
35. Furukawa M, Andrews PS, Xiong Y. Assays for RING family ubiquitin ligases. Methods Mol Biol 2005; 301: 37-46.